the BioLattice Team
Our aim is to transform innovative ideas into medical products as a means of expanding patient access to solutions that restore, repair or rebuild damaged cornea tissue.
We are developing partnerships with potential technology licensees and multiple contract organizations to market the engineered cornea. Revenue generating strategies include:
- Corporate co-development and sales
- BioLattice development through clinical trials followed by direct sales